Important Update: Changes to Tirzepatide Prescriptions and Exciting New Insurance Options!

Changes to Tirzepatide Prescriptions

As of October 2, 2024, the FDA announced that compounded Tirzepatide prescriptions will no longer be processed by compounding pharmacies. This decision comes as part of the FDA’s broader effort to regulate compounded GLP-1 medications, with the national supply of GLP-1 drugs such as Tirzepatide stabilizing. This update means that the availability of compounded Tirzepatide is ending, and pharmacies will no longer fill these prescriptions moving forward.

What This Means for You

• Pending 3-Month Tirzepatide Orders: If your compounded Tirzepatide order was not filled before October 1, 2024, it will no longer be processed. To support you in this transition, we are offering account credits to help you switch to Semaglutide as an alternative medication.
• Non-3-Month Orders: If you placed an order for less than 3 months of compounded Tirzepatide, we are providing a full refund for your purchase.
• 3-Month Package Credits: For those who purchased 3-month packages of Tirzepatide, you will receive a $299 credit per remaining month to use toward another service or medication.

Great News for Semaglutide Clients

For clients transitioning from compounded Tirzepatide to Semaglutide, there is some great news! We are now offering 3-month Semaglutide packages, which will be shipped all at once, with shipping beginning within 14 days. This convenient new process will allow you to receive all 3 vials in a single delivery, simplifying your treatment plan.

Exciting New Insurance Billing Options

We are excited to announce that Life IV Weight Loss is actively working on credentialing our office to bill insurance for the full weight loss treatment process. This new service will include:

• Office visits and consultations
• Prescriptions for weight loss medications, including retail pharmacy options for Semaglutide

Our goal is to make weight loss medications even more affordable and accessible for our clients. Stay tuned for further updates as we expand these insurance billing options!

Have Questions? We’re Here to Help!

We understand that the end of compounded Tirzepatide availability may raise concerns, and we want to assure you that we are here to support you. Please reach out to us if you have any questions about transitioning to Semaglutide, receiving refunds, or credits on your account.

Thank you for your continued trust in Life IV Weight Loss. We are committed to helping you navigate these changes and continue your weight loss journey with the best possible care!

With appreciation,
Justin and The Life IV Weight Loss Team

External Sources:

• FDA Clarifies Policies on Compounding GLP-1 Medications